The Madison Avenue effect: How drug presentation style influences adherence and outcome in patients with asthma

Emmanuelle M. Clerisme-Beaty, Susan J. Bartlett, W. Gerald Teague, John Lima, Charles G. Irvin, Rubin Cohen, Mario Castro, Robert A Wise, Cynthia S Rand

Research output: Contribution to journalArticle

Abstract

Background: Little is known about how drug presentation influences medication adherence. Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence. Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV1, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up. Results: Average electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P <.001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence. Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.

Original languageEnglish (US)
Pages (from-to)406-411
Number of pages6
JournalThe Journal of Allergy and Clinical Immunology
Volume127
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Medication Adherence
Asthma
montelukast
Pharmaceutical Preparations
Placebos
Quality of Life
Juniperus
Drug Monitoring
Patient Education
Multicenter Studies
Odds Ratio

Keywords

  • Asthma
  • behavioral intervention
  • electronic monitoring
  • medication adherence
  • outcome expectancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The Madison Avenue effect : How drug presentation style influences adherence and outcome in patients with asthma. / Clerisme-Beaty, Emmanuelle M.; Bartlett, Susan J.; Teague, W. Gerald; Lima, John; Irvin, Charles G.; Cohen, Rubin; Castro, Mario; Wise, Robert A; Rand, Cynthia S.

In: The Journal of Allergy and Clinical Immunology, Vol. 127, No. 2, 02.2011, p. 406-411.

Research output: Contribution to journalArticle

Clerisme-Beaty, Emmanuelle M. ; Bartlett, Susan J. ; Teague, W. Gerald ; Lima, John ; Irvin, Charles G. ; Cohen, Rubin ; Castro, Mario ; Wise, Robert A ; Rand, Cynthia S. / The Madison Avenue effect : How drug presentation style influences adherence and outcome in patients with asthma. In: The Journal of Allergy and Clinical Immunology. 2011 ; Vol. 127, No. 2. pp. 406-411.
@article{92a14a4edc1d4842bf8d42b0a6df8644,
title = "The Madison Avenue effect: How drug presentation style influences adherence and outcome in patients with asthma",
abstract = "Background: Little is known about how drug presentation influences medication adherence. Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence. Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥80{\%} use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV1, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up. Results: Average electronic medication adherence was 69.9{\%}. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P <.001) and better medication adherence (odds ratio, 4.0; 95{\%} CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence. Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.",
keywords = "Asthma, behavioral intervention, electronic monitoring, medication adherence, outcome expectancy",
author = "Clerisme-Beaty, {Emmanuelle M.} and Bartlett, {Susan J.} and Teague, {W. Gerald} and John Lima and Irvin, {Charles G.} and Rubin Cohen and Mario Castro and Wise, {Robert A} and Rand, {Cynthia S}",
year = "2011",
month = "2",
doi = "10.1016/j.jaci.2010.11.038",
language = "English (US)",
volume = "127",
pages = "406--411",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - The Madison Avenue effect

T2 - How drug presentation style influences adherence and outcome in patients with asthma

AU - Clerisme-Beaty, Emmanuelle M.

AU - Bartlett, Susan J.

AU - Teague, W. Gerald

AU - Lima, John

AU - Irvin, Charles G.

AU - Cohen, Rubin

AU - Castro, Mario

AU - Wise, Robert A

AU - Rand, Cynthia S

PY - 2011/2

Y1 - 2011/2

N2 - Background: Little is known about how drug presentation influences medication adherence. Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence. Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV1, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up. Results: Average electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P <.001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence. Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.

AB - Background: Little is known about how drug presentation influences medication adherence. Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence. Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV1, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up. Results: Average electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P <.001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence. Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.

KW - Asthma

KW - behavioral intervention

KW - electronic monitoring

KW - medication adherence

KW - outcome expectancy

UR - http://www.scopus.com/inward/record.url?scp=79551472661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551472661&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2010.11.038

DO - 10.1016/j.jaci.2010.11.038

M3 - Article

C2 - 21281871

AN - SCOPUS:79551472661

VL - 127

SP - 406

EP - 411

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -